ClinicalTrials.Veeva

Menu

Anesthesia for Obese Patients: Desflurane Versus Xenon (XENON)

C

Centre Hospitalier Universitaire de Nīmes

Status and phase

Completed
Phase 4

Conditions

Obesity

Treatments

Drug: Desflurane
Drug: Xenon

Study type

Interventional

Funder types

Other

Identifiers

NCT01167803
PHRC-I/2009/EN-01
2009-017126-39 (EudraCT Number)

Details and patient eligibility

About

Obesity is increasing in France, resulting in an increased demand for bariatric surgery. However obesity also alters physiopathological pathways and the pharmacokinetics of anesthestic agents. The investigators objective is to compare, among morbidly obese patients, the immediate and intermediary emergence kinetics after balanced anesthesia using remifentanil associated either with desflurane (reference arm) or with xenon (experimental arm).

Enrollment

192 patients

Sex

All

Ages

18 to 65 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • American Society of Anesthesiologists (ASA) I to III
  • requires bariatric surgery
  • body mass index (BMI) >= 35 kg/m2
  • patient speaks and writes French
  • patient has signed consent form
  • patient enrolled in a social security program

Exclusion criteria

  • patient refuses to sign consent
  • ASA IV or more
  • patient is pregnant or breastfeeding
  • history of hyperthermy (or suspicion, or family history thereof)
  • history of liver disease, icterus, unexplained fever, or eosinophilia after administration of a halogen anesthesia
  • patient has symptomatic gastro-oesophagean reflux
  • patient has hypersensitivity to one or more of the following substances: propofol, remifentanil, celocurine, cisatracurium, rocuronium, desflurane, xenon, paracetamol, ketoprofen, nefopam, tramadol
  • patient has obstructive respiratory failure (chronic obstruction pneumopathy, asthma) or has heart disease with severly altered cardiac function
  • patient has high intracranial pressure
  • patient requires high concentrations of oxygen (fio2>40%)
  • patient has a neuro-sensorial deficient which prevents reading, writing, or response to simple oral commands (severe deafness, language impairment...)in the absence of a prothesis
  • patient has a psychiatric pathology, or chronically consumes alcohol or other mind-altering substance
  • patient has had general anesthesia in the last 15 days
  • patient under guardianship
  • impossible to correctly communicate information to the patient
  • absence of efficient contraception for women of childbearing age
  • participation in another study within the last 3 months

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

192 participants in 2 patient groups

Reference - desflurane
Active Comparator group
Description:
The patients in this group will undergo anesthesia using remifentanil associated with desflurane.
Treatment:
Drug: Desflurane
Experimental - xenon
Experimental group
Description:
The patients in this group will undergo anesthesia using remifentanil associated with xenon
Treatment:
Drug: Xenon

Trial contacts and locations

6

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems